Clinical manifestations are complex and often involve multiple systems. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of this disease requires a combination of clinical manifestations, imaging inspections, laboratory tests and pathological evaluation.
The platform can help align national and international experts and teams to provide accurate diagnoses and treatment programs. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult-to-treat genetic metabolic disorders have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, with timely adjustment according to the changes in the disease.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of carcinogenicity. The platform serves a team of internationally authoritative experts in the field of genetic metabolism at home and abroad in China's international medical service system, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.